Convatec's Guidance Upgrade Should Reassure Investors — Market Talk
Convatec Group's performance update should ease concerns about the medical device company reaching its 2026 guidance, J.P. Morgan analysts write. There had been concerns about the step-up needed in the second half for Convatec to meet its 2026 forecasts, JPM notes. However, the upgrade to top-line…